The androgenicity of progestins

Stanczyk, 1990, Metabolism of levonorgestrel norethindrone, and structurally related contraceptive steroids, Contraception, 42, 67, 10.1016/0010-7824(90)90093-B Meade, 1980, Progestogens and cardiovascular reac-tions associated with oral contraceptives and a comparison of the safety of 50 and 30-microgram oestrogen preparations, Br Med J, 280, 1157, 10.1136/bmj.280.6224.1157 Kay, 1982, Progestagens and arterial disease—evidence from the Royal College of General Practitioners' study, Am J Obstet Gynecol, 142, 758, 10.1016/S0002-9378(16)32485-1 Hirvonen, 1990, Cardiovascular death among women under 40 years of age using low-estrogen oral contraceptives and intrauterine devices in Fin-land from 1975 to 1984, Am J Obstet Gynecol, 163, 281, 10.1016/0002-9378(90)90568-R Stampfer, 1988, A prospective study of past use of oral contraceptive agents and the risk of cardiovascular dis-eases, N Engl J Med, 319, 1313, 10.1056/NEJM198811173192004 Porter, 1987, Mortality among oral contraceptive users, Obstet Gynecol, 70, 29 Upmalis, 1991, Receptor binding and in vivo activities of the new progestins, JSOGC, 13, 35 Fotherby, 1994, New progestins in oral contraception, Contraception, 49, 1, 10.1016/0010-7824(94)90106-6 Hammond, 1984, Serum steroid binding protein concen-trations and bioavailability of testosterone with oral contraceptives, Fertil Steril, 42, 44, 10.1016/S0015-0282(16)47956-2 Chapdelaine, 1989, Clinical evidence of the minimal andro-genic activity of norgestimate, Int J Fertil, 34, 347 van der Vange, 1990, Effects of seven low-dose combined oral contraceptives on sex hormone binding globulin, corticosteroid binding globulin total and free testosterone, Contraception, 41, 345, 10.1016/0010-7824(90)90034-S Mall-Haefali, 1991, Biochemical and clinical results with the new micropill Cilest, 53 Jung-Hoffmann, 1988, Effect of two oral contraceptives containing 30 micrograms ethinyl estradiol and 75 micrograms gestodene or 150 micrograms desogestrel upon various hormonal parameters, Contraception, 38, 593, 10.1016/0010-7824(88)90044-3 Cullberg, 1984, Androgenic, oestrogenic and antioestrogenic effects of desogestrel and lynestrenol alone: effects of serum proteins, sex hormones and vaginal cytology, 17 Song, 1993, Effects of different doses of norethisterone on ovarian function, serum sex hormone binding globulin and high density lipoprotein-cholesterol, Contraception, 47, 527, 10.1016/0010-7824(93)90021-X Bergink, 1983, Binding of progestogens to receptor proteins in MCF-7 cells, J Steroid Biochem, 19, 1563, 10.1016/0022-4731(83)90371-0 Refn, 1990, Clinical and hormonal effects of two contraceptives: correlation to serum concentrations of levonorgestrel and gestodene, Contraception, 41, 259, 10.1016/0010-7824(90)90067-6 Song, 1992, A cross-over study of three oral contraceptives containing ethinyl oestradiol and either desogestrel or levonorgestrel, Contraception, 45, 523, 10.1016/0010-7824(92)90103-Z Palatsi, 1984, Serum total and unbound testosterone and sex hormone binding globulin in female acne patients treated with two different oral contraceptives, Acta Derm Venereol (Stockh), 64, 517, 10.2340/0001555564517523 Kloosterboer, 1987, Acta Obstet Gynecol Scand Suppl, 144, 41, 10.3109/00016348709156495 Grunwald, 1991, Clinical tolerance of a low-dose norgestimate-containing combination oral contraceptive (Cilest) in a West Germany multicenter study (Heidelberg Multicenter Oral Contraceptive Study), 67 Geissler, 1989, Influence of a combination of desogestrel and ethinyl estradiol on acne vulgaris in women seeking contraception; results of an open non-comparative, multicenter trial, TW Gynaekol, 2, 321 Bilotta, 1988, Clinical evaluation of a monophasic ethinyl estradiol/ desogestrel-containing oral contraceptive, Arzneimittelforschung, 38, 932 Cullberg, 1985, Effects of desogestrel/ethinyl estra-diol in hirsutism and rogens and SHBG, Acta Obstet Gynecol Scand, 64, 195, 10.3109/00016348509155112 Porcile, 1991, Oral contraceptives containing desogestrel in hirsutism, Contraception, 44, 533, 10.1016/0010-7824(91)90155-9 Venturoli, 1988, The effects of desogestrel and ethinylestra-diol combination in normal and hyperandrogenic young girls: speculations on contra-ception in adolescence, Acta Eur Fertil, 19, 129 Nappi, 1990, Effect of desogestrel with 20 or 30 micrograms ethinyl estradiol in adolescents with hyperandrogenism, 757 Sobrio, 1991, SBHG, CBG and ceruloplasmin changes with two low dose oral contraceptives, Clin Exp Obstet Gynecol, 18, 43 Runnebaum, 1992, The efficacy and olerability of norgestimate/ ethinyl estradiol: results of an open multicenter study of 59, 701 women, Am J Obstet Gynecol, 166, 1963, 10.1016/0002-9378(92)91396-R Corson, 1990, Efficacy and clinical profile of a new oral contraceptive containing norgestimate: U.S. clinical trials, Acta Obstet Gynecol Scand Suppl, 152, 25, 10.3109/00016349009156503 Hoppe G., 1988, an innovative progestin, Contraception, 37, 29, 10.1016/0010-7824(88)90019-4 Affandi, 1987, The interaction between sex hormone binding globulin and levonorgestrel released from Norplant, an implantable contraceptive, Contraception, 35, 135, 10.1016/S0010-7824(87)80004-5 Darney, 1990, Sustained release contraceptives, Curr Prob Obstet Gynecol Fertil, 13, 87 Olsson, 1990, Clinical results with subcutaneous implants containing 3-ketodesogestrel, Contraception, 42, 1, 10.1016/0010-7824(90)90087-C Patsch, 1989, The effect of triphasic oral contraceptives on plasma lipids and lipoproteins, Am J Obstet Gynecol, 161, 1396, 10.1016/0002-9378(89)90703-5 Ball, 1990, Comparison of two triphasic contracep-tives with different progestogens: effects on metabolism and coagulation proteins, Contraception, 41, 363, 10.1016/0010-7824(90)90036-U Refn, 1990, Meta-bolic changes during treatment with two different progestogens, Am J Obstet Gyne-col, 163, 374, 10.1016/0002-9378(90)90585-U Weber-Diehl, 1993, Comparison of two triphasic oral contracep-tives containing either gestodene or norethindrone: a randomized controlled trial, Contraception, 48, 291, 10.1016/0010-7824(93)90076-J Janaud, 1992, A comparison study of lipid and andro-gen metabolism with triphasic oral contraceptive formulations containing norgest-imate of levonorgestrel, Acta Obstet Gynecol Scand Suppl, 156, 33, 10.3109/00016349209156513 Kirkman, 1994, Clinical comparison of two low-dose oral contraceptives, Minulet Mercilon, in women over 30 years of age, Contraception, 49, 33, 10.1016/0010-7824(94)90107-4 Anderson, 1992, Selectivity and minimal androgenicity of norgestimate in mono-phasic and triphasic oral contraceptives, Acta Obstet Gynecol Scand, 71, 15, 10.3109/00016349209156510 Rekers, 1988, Multicenter trial of a monophasic oral contraceptive containing ethinyl estradiol and desogestrel, Acta Obstet Gynecol Scand, 67, 171, 10.3109/00016348809004193 Dusterberg, 1990, Clinical acceptability of monophasic gestodene, Am J Obstet Gynecol, 163, 1398, 10.1016/0002-9378(90)91355-G Darney, 1993, Efficacy and safety of triphasic DSG/EE, Contraception, 48, 323, 10.1016/0010-7824(93)90078-L Cullberg, 1982, Two oral contraceptives, efficacy serum proteins lipid metabolism. A comparative multicentre study on a triphasic and a fixed dose combination, Contraception, 26, 229, 10.1016/0010-7824(82)90072-5